FDA.reportPublic FDA data

Baxdela 300 MG Injection

RxCUI
1927672
RxNorm name
Baxdela 300 MG Injection
Display name
Baxdela 300 MG Injection
Full name
Baxdela 300 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BaxdelaDELAFLOXACIN MEGLUMINEMelinta Therapeutics, LLCfb77637a-88d9-4aea-958f-e270030ce30d2025-08-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1927672

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
fb77637a-88d9-4aea-958f-e270030ce30dBaxdela 300 MG Injection [PSN] · delafloxacin 300 MG Injection [Baxdela] [SBD] · Baxdela 300 MG (as delafloxacin meglumine 433 MG) Injection [SY] · Baxdela 300 MG Injection [SY]421These highlights do not include all the information needed to use BAXDELA ® safely and effectively. See full prescribing information for BAXDELA. BAXDELA (delafloxacin) tablets, for oral use BAXDELA (delafloxacin) for injection, for intravenous use Initial U.S. Approval: 201720250801